Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria

Food and Chemical Toxicology

Volumn 48, Issue 7, 2010, Pages 1973-1979

  Tabassum, Heena ^a,b,c   Parvez, Suhel ^c   Pasha, Syed Tazeen ^d   Banerjee, Basu Dev ^b   Raisuddin, Sheikh ^a  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^c LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^d NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

Author keywords

Lipid peroxidation; Lipoic acid; Methotrexate; Mitochondria; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; FREE RADICAL; GLUTATHIONE; METHOTREXATE; MITOCHONDRIAL PROTEIN; SUPEROXIDE; THIOCTIC ACID; THIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; LIPID PEROXIDATION; LIVER MITOCHONDRION; LIVER PROTECTION; MITOCHONDRIAL TOXICITY; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; BODY WEIGHT; DNA; FOLIC ACID ANTAGONISTS; FREE RADICALS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID METABOLISM; METHOTREXATE; MICE; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; SUPEROXIDES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID;

MUS;

EID: 77953544509     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.04.047     Document Type: Article

References (52)

1. Aly H.A., Lightfoot D.A., El-Shemy H.A. Modulatory role of lipoic acid on lipopolysaccharide-induced oxidative stress in adult rat Sertoli cells in vitro. Chem. Biol. Interact. 2009, 182:112-118.
2. Anderson H., Scarffe J.H., Ranson M., Young R., Wieringa G.S., Morgenstern G.R., Fitzsimmons L., Ryder D. VAD chemotherapy as remission induction for multiple myeloma. Br. J. Cancer 1995, 71:326-330.
3. Babiak R.M., Campello A.P., Carnieri E.G., Oliveira M.B. Methotrexate: pentose cycle and oxidative stress. Cell Biochem. Funct. 1998, 16:283-293.
4. Balsano C., Alisi A. Antioxidant effects of natural bioactive compounds. Curr. Pharm. Des. 2009, 15:3063-3073.
5. Biewenga G.P., Haenen G.R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 1997, 29:315-331.
6. Biswas S., Chida A.S., Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem. Pharmacol. 2006, 71:551-564.
7. Bradford M.M. A rapid and sensitive MTXhod for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
8. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302-310.
9. Bustamante J., Lodge J.K., Marcocci L., Tritschler H.J., Packer L., Rihn B. Alpha-lipoic acid in liver metabolism and disease. Free Radic. Biol. Med. 1998, 24:1023-1039.
10. Caetano N.N., Campello A.P., Carnieri E.G., Kluppel M.L., Oliveira M.B. Effect of methotrexate (MTX) on NAD(P)+ dehydrogenases of HeLa cells: malic enzyme, 2-oxoglutarate and isocitrate dehydrogenases. Cell Biochem. Funct. 1997, 15:259-264.
11. Calabrese V., Lodi R., Tonon C., D'Agata V., Sapienza M., Scapagnini G., Mangiameli A., Pennisi G., Stella A.M., Butterfield D.A. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 2005, 233:145-162.
12. Cetinkaya A., Bulbuloglu E., Kurutas E.B., Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med. Sci. Monit. 2006, 12:274-278.
13. Chládek J., Martínková J., Sispera L. An in vitro study on methotrexate hydroxylation in rat and human liver. Physiol. Res. 1997, 46:371-379.
14. Corbisier P., Raes M., Michiels C., Pigeolet E., Houbion A., Delaive E., Remacle J. Respiratory activity of isolated rat liver mitochondria following in vitro exposure to oxygen species: a threshold study. Mech. Ageing Dev. 1990, 51:249-263.
15. Flohé L., Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
16. Flohé L., Otting F. Superoxide dismutase assays. Methods Enzymol. 1984, 105:93-104.
17. Galivan J., Balinska M. Studies of formation and efflux of methotrexate polyglutamates with cultured hepatic cells. Adv. Exp. Med. Biol. 1983, 163:235-246.
18. Ghezzi P. Oxidoreduction of protein thiols in redox regulation. Biochem. Soc. Trans. 2005, 33:1378-1381.
19. Grattagliano I., Bonfrate L., Diogo C.V., Wang H.H., Wang D.Q., Portincasa P. Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J. Gastroenterol. 2009, 15:4865-4876.
20. Han D., Handelman G., Marcocci L., Sen C.K., Roy S., Kobuchi H., Tritschler H.J., Flohé L., Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997, 6:321-338.
21. Hissin P.J., Hilf R.A. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
22. Horie T., Nakamaru M., Masubuchi Y. Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sci. 1998, 62:1333-1338.
23. Hoye A.T., Davoren J.E., Wipf P., Fink M.P., Kagan V.E. Targeting mitochondria. Acc. Chem. Res. 2008, 41:87-97.
24. Hsu P.C., Lan J.L., Hsieh T.Y., Jan Y.J., Huang W.N. Methotrexate pneumonitis in a patient with rheumatoid arthritis. J. Microbiol. Immunol. Infect. 2003, 36:137-140.
25. Iqbal M.P., Sultana F., Mehboobali N., Pervez S. Folinic acid protects against suppression of growth by methotrexate in mice. Biopharm. Drug Dispos. 2001, 22:169-178.
26. Jahovic N., Cevik H., Sehirli A.O., Yeĝen B.C., Sener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J. Pineal Res. 2003, 34:282-287.
27. Johnston J.A., Johnson E.S., Waller P.R., Varshavsky A. Methotrexate inhibits proteolysis of dihydrofolate reductase by the N-end rule pathway. J. Biol. Chem. 1995, 270:8172-8178.
28. Kamen B.A., Nylen P.A., Camitta B.M., Bertino J.R. Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug. Br. J. Haematol. 1981, 49:355-360.
29. Kopytek S.J., Standaert R.F., Dyer J.C., Hu J.C. Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate. Chem. Biol. 2000, 7:313-321.
30. Koyama S., Sato E., Takamizawa A., Tsukadaira A., Haniuda M., Kurai M., Numanami H., Nagai S., Izumi T. Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. Exp. Lung Res. 2003, 29:91-111.
31. Krähenbühl S. Mitochondria: important target for drug toxicity?. J. Hepatol. 2001, 34:334-336.
32. Lin J., Bierhaus A., Bugert P., Dietrich N., Feng Y., Vom Hagen F., Nawroth P., Brownlee M., Hammes H.P. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia 2006, 49:1089-1096.
33. Lu C., Liu Y. Interactions of lipoic acid radical cations with vitamins C and E analogue and hydroxycinnamic acid derivatives. Arch Biochem. Biophys. 2002, 406:78-84.
34. Madesh M., Balasubramanian K.A. A microtiter plate assay for superoxide using MTT reduction method. Indian J. Biochem. Biophys. 1997, 34:535-539.
35. Mruk D.D., Silvestrini B., Mo M.Y., Cheng C.Y. Antioxidant superoxide dismutase - a review: its function, regulation in the testis, and role in male fertility. Contraception 2002, 65:305-311.
36. Neuman M.G., Cameron R.G., Haber J.A., Katz G.G., Malkiewicz I.M., Shear N.H. Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity. Clin. Biochem. 1999, 32:519-536.
37. Oliveira M.B., Campello A.P., Klüppel W.L. Methotrexate: studies on cellular metabolism. III. - Effect on the transplasma-membrane redox activity and on ferricyanide-induced proton extrusion by HeLa cells. Cell Biochem. Funct. 1989, 7:135-137.
38. Packer L., Witt E.H., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 1995, 19:227-250.
39. Packer L., Tritschler H.J., Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med. 1997, 22:359-378.
40. Parvez S., Tabassum H., Banerjee B.D., Raisuddin S. Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice. Basic Clin. Pharmacol. Toxicol. 2008, 102:382-387.
41. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1968, 25:192-205.
42. Selvakumar E., Prahalathan C., Mythili Y., Varalakshmi P. Beneficial effects of dl-alpha-lipoic acid on cyclophosphamide-induced oxidative stress in mitochondrial fractions of rat testis. Chem. Biol. Interact. 2005, 152:59-66.
43. Sohal R.S., Kamzalov S., Sumien N., Ferguson M., Rebrin I., Heinrich K.R., Forster M.J. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice. Free Radic. Biol. Med. 2006, 40:480-487.
44. Stankiewicz A., Skrzydlewska E., Makieła M. Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol. Drug Interact. 2002, 19:67-82.
45. Starkov A.A., Wallace K.B. Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol. Sci. 2002, 66:244-252.
46. Szewczyk A., Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 2002, 54:101-127.
47. Tabassum H., Parvez S., Rehman H., Banerjee B.D., Siemen D., Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Hum. Exp. Toxicol. 2007, 26:509-518.
48. Toffoli G., Corona G., Gigante M., Boiocchi M. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line. Eur. J. Cancer 1996, 32:1591-1597.
49. Turesson C., Matteson E.L. Genetics of rheumatoid arthritis. Mayo Clin. Proc. 2006, 81:94-101.
50. Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7:65-74.
51. Yamamoto N., Lopes L.C., Campello A.P., Klüppel M.L. Methotrexate: studies on cellular metabolism. II - Effects on mitochondrial oxidative metabolism and ion transport. Cell Biochem. Funct. 1989, 7:129-134.
52. Yamamoto N.S., Ishii-Iwamoto E.L., Bracht A. Activation of glycogenolysis by methotrexate. Influence of calcium and inhibitors of hormone action. Biochem. Pharmacol. 1992, 44:761-767.